MedTrace Logo

Excimer Laser Trabeculostomy Glaucoma Treatment Study

NCT04899063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2025-09-30

No results posted yet for this study

Summary

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG) undergoing cataract surgery

Conditions

  • Glaucoma, Primary Open Angle

Interventions

DEVICE

ELIOS Procedure

Treatment with the ELIOS System

Sponsors & Collaborators

  • Elios Vision, Inc.

    lead INDUSTRY

Principal Investigators

  • Iqbal (Ike) Ahmed, MD · Prism Eye Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2025-07-29
Completion
2025-07-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899063 on ClinicalTrials.gov